Press Release|Articles|April 29, 2025
Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP
Listen
0:00 / 0:00
Key Takeaways
- Chlorzoxazone Tablets, USP, target relief from acute, painful musculoskeletal conditions as an adjunct therapy.
- The tablets are intended to complement rest, physical therapy, and other treatment measures.
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Chlorzoxazone Tablets, USP.
Chlorzoxazone Tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
Chlorzoxazone 250 mg Tablets, USP are available in 60 count bottles.
To find out more information on Chlorzoxazone Tablets, USP, please visit:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis on the Rise in the United States, Exceeding 450 Cases
2
Kidney Disease Rates Hold Steady for a Decade as Diabetes-Driven Cases Climb
3
Same-Day COVID-19 and Flu Vaccination Does Not Raise Adverse Event Risk, Large VA Study Finds
4
Reducing Recurrence in C Difficile Infection
5